ADA Wrap-Up: Where's The Chocolate?

Trying to understand all that data released at the American Diabetes Association’s 68th Scientific Sessions in San Francisco? Attempting to make sense of the company posturing and resulting fallout in the marketplace? It’s enough to make anyone a little hypoglycemic. But getting a handle on the market potential of the various medicines in the lucrative Type II diabetes space, such as Januvia and Byetta, is worth a potential sugar low. Here's a quick review for those who need it. By 2012 a ga